New Juice-Based Probiotic Shows Hope for Multiple Sclerosis Management

Groundbreaking Study for Multiple Sclerosis

A recent study has shown that a new juice-based probiotic medical food can completely inhibit the harmful bacteria linked to Multiple Sclerosis (MS). This promising development could change how MS is managed through diet.

MS is a disease that impacts the nervous system, often leading to disability in young adults. Until now, there have been limited options for managing MS symptoms without undesirable side effects. This new probiotic food could be a game-changer by targeting a known bacteria associated with MS.

The Role of Epsilon Toxin-Producing Bacteria

Researchers have identified that a bacteria called Clostridium perfringens can produce toxins potentially triggering MS. Up to now, there has been no specific dietary supplement to manage this bacteria effectively.

The recent study led by Dr. A. Reza Kamarei and his team has shown that a specific juice-based probiotic can inhibit this harmful bacteria. This is a major step towards specialized dietary management for MS patients.

How the Probiotic Works

The medical food developed by Doctor's Biome uses a special blend of probiotics in an organic juice base. The study demonstrated that this blend could completely inhibit the growth of the harmful Clostridium perfringens bacteria.

The probiotics are delivered in a sterilized liquid juice, providing a user-friendly way for patients to manage their MS symptoms through diet.

Expert Opinions and Future Prospects

Doctor's Biome CEO Richard Finkelstein expressed excitement over this innovation. He emphasized the company's mission to lead in creating clinically validated probiotics.

Chief Science and Technology Officer Dr. A. Reza Kamarei highlighted the importance of this development, noting that it wouldn't have been possible without the team's dedicated efforts and collaboration.

Practical Applications and Next Steps

This new medical food offers a promising option for MS patients under a physician's supervision. It contains 60 billion colony-forming units of the proprietary probiotic blend in 2 oz. of sterilized juice.

Doctor's Biome is open to further clinical trials and welcomes feedback from the medical community to enhance this innovative product further.

About Doctor's Biome

Doctor's Biome, based in New York, specializes in developing and marketing clinically tested probiotics in sterilized organic vegetable and fruit juices.

For more information, visit their website at www.DoctorsBiome.com or contact David Finkelstein via phone or email.